Publications by authors named "Duncan Gilbert"

Claim this Profile
P
Preferences between three options for androgen deprivation therapy: a focus group study.
Hannah L Rush, Sophie Merrick, John Marshall, John Deighan, Hoda Abdel-Aty, Duncan C Gilbert

BJU Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trial.
Russell Frood, Alexandra Gilbert, Duncan Gilbert, Natalie L Abbott, Susan D Richman

BMJ Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the Impact of Histology on the Incidence, Pattern, and Timing of Recurrences in Patients with Renal Cell Carcinoma: A Pooled Analysis from the SORCE and ASSURE Trials.
Bhavna Oza, Eleni Frangou, Tim Eisen, Grant D Stewart, Axel Bex, Duncan Gilbert

Eur Urol Open Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conduct of cancer clinical trials: a qualitative study reporting views of patients, caregivers, public and clinical researchers.
Soumitra S Datta, Bidisha Samanta, Sanjoy Chatterjee, Indranil Mallick, Atul Sharma, Duncan Gilbert

Ecancermedicalscience· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Silke Gillessen, Laura Murphy, Nicholas D James, Ashwin Sachdeva, Omar El-Taji, Duncan C Gilbert

Lancet Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating ePROMs: A key opportunity for England's National Cancer Plan.
Sally Wheelwright, Ollie Minton, Kate Absolom, Corinne Faivre-Finn, Lesley Fallowfield, Alexandra Gilbert, Duncan Gilbert

J Cancer Policy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial.
Alexandra Gilbert, Richard Adams, Joanne Webster, Duncan C Gilbert, Natalie L Abbott

Lancet Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the optimal use of approved drugs in oncology.
Gauthier Bouche, Duncan Gilbert, Matteo Quartagno, Hakim-Moulay Dehbi, Sophie Merrick

Lancet Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non-Inferiority.
Hakim-Moulay Dehbi, Sean Devlins, Alexia Iasonos, Matthew Nankivell, Duncan Gilbert

Stat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition.
Sophie Merrick, Hannah L Rush, Susanna Daniels, Alison Fielding, Sharon Deveson Kell, Duncan C Gilbert

Br J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.
Matthew R Sydes, Macey L Murray, Saiam Ahmed, Sophia Apostolidou, Judith M Bliss, Duncan C Gilbert

Contemp Clin Trials· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Bertrand Tombal, Sean Collins, Alicia K. Morgans, et al. Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. Eur Urol 2023;84:579-87.
Hannah L Rush, Duncan C Gilbert, Ruth E Langley

Eur Urol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the molecular biology of anal squamous cell carcinoma.
Robert J Samuel, Duncan C Gilbert

Int J Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review.
Hannah Louise Bromley, Mohini Varughese, Duncan C Gilbert, Peter Hoskin, Ian F Tannock

BMJ Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies.
Pablo Nenclares, Adrian Larkeryd, Floriana Manodoro, Jen Y Lee, Susan Lalondrelle, Duncan C Gilbert

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials.
Matteo Quartagno, Tim P Morris, Duncan C Gilbert, Ruth E Langley, Matthew G Nankivell

Clin Trials· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shooting the messenger: a systematic review investigating extracellular vesicle isolation and characterisation methods and their influence on understanding extracellular vesicles-radiotherapy interactions in glioblastoma.
Stephen David Robinson, Mark Samuels, William Jones, Duncan Gilbert, Giles Critchley

BMC Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular health: an important component of cancer survivorship.
Siobhan Cleary, Stuart D Rosen, Duncan C Gilbert, Ruth E Langley

BMJ Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.
Nalinie Joharatnam-Hogan, Duaa Hatem, Fay H Cafferty, Giovanna Petrucci, David A Cameron, Duncan C Gilbert

Br J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected data.
Archie Macnair, Matthew Nankivell, Macey L Murray, Stuart D Rosen, Sally Appleyard, Duncan C Gilbert

Contemp Clin Trials· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Gerhardt Attard, Laura Murphy, Noel W Clarke, Ashwin Sachdeva, Craig Jones, Duncan Gilbert

Lancet Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment.
Ehsan Ghorani, Matteo Quartagno, Fiona Blackhall, Duncan C Gilbert, Mary O'Brien

Lancet Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire.
Samantha C Sodergren, Colin D Johnson, Alexandra Gilbert, Anne-Sophie Darlington, Kim Cocks, Duncan C Gilbert

Int J Radiat Oncol Biol Phys· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing alternative schedules of adjuvant immune checkpoint blockers - The need for well-designed clinical trials.
Gauthier Bouche, Ruth Langley, Hannah Rush, Mahesh Parmar, Duncan C Gilbert

Eur J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers.
Sophie Merrick, Matthew Nankivell, Matteo Quartagno, Caroline S Clarke, Nalinie Joharatnam-Hogan, Duncan C Gilbert

Contemp Clin Trials· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis